Results 91 to 100 of about 18,836 (198)
Posaconazole conformation.
, 2013 A. Fragments of the Fo-Fc electron density map (grey mesh) in chains A, B and D calculated with the posaconazole coordinates omitted from the input file. B, C.Matthew P. Jacobson (174588), James H. McKerrow (113918), Christophe Guilbert (365836), Siegfried S. F. Leung (365835), Larissa M. Podust (145743), Chiung-Kuang Chen (145721) +5 morecore +1 more sourcePrediction of Tacrolimus–Posaconazole Interactions in Renal Transplant Patients with Different CYP3A5 Genotypes, Based on Physiological Pharmacokinetic Models
PharmaceuticsObjective: Posaconazole, a second-generation triazole antifungal used for the prevention or treatment of invasive fungal infections, has been shown to markedly increase tacrolimus exposure in vivo when co-administered, potentially leading to clinically ...Mengmeng Guan, Wanyi Zhou, Haoran Qin, Yi Xu, Di Zhao, Hui Xue, Nan Hu +6 moredoaj +1 more sourceBenznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial [PDF]
, 2017 BACKGROUND Benznidazole is recommended for treatment of Chagas infection. Effects of combination therapy with benznidazole and posaconazole have not been tested in Trypanosoma cruzi carriers.McCarthy, Michael, Molina, Israel, Meeks, Brandi, Perez-Molina, Jose Antonio, Cuneo, Carlos, Yusuf, Salim, Milesi, Rodolfo, Wyss, Fernando, Colombo, Hugo, Del Carmen Bangher, Maria, Bonilla, Laura R, Mallagray, Marcelo, Gao, Peggy, Waskin, Hetty, Morillo, Carlos A, Sosa-Estani, Sergio, Wei, Bo, Beloscar, Juan, Gascon, Joaquim, Apt, Werner, Echeverria, Luis E, M.A. Berli, M. Dellatorre, E. Reyes, N.E. Cáceres, Julio Lazzari, E. Rodríguez, Maria del Carmen Bangher, Carlos Cuneo, Jose Antonio Perez-Molina, D. Isaza, Robin Roberts, Laura R. Bonilla, M.H. Mallagray, W. Apt, M.A. Romero, Michael McCarthy, N.C. Gutiérrez, Y. Hernández, Mahmoud Traina, J.M. Petrucci, K. Scollo, J. Gascon, N. Serret, I. Guzmán Melgar, Carlos A. Morillo, A. Riarte, R. López-Vélez, Peggy Gao, C.A. Cuneo, Harry Acquatella, Amanda Taylor, A. Sánchez-Montalvá, A. Figueroa, Luis E. Echeverria, Salim Yusuf, Juan Beloscar, H. Colombo, E. Aldasoro, Israel Molina, Rafael Diaz, P.A. Reyes-López, Bo Wei, F.S. Wyss, Aldo Prado, Joaquim Gascon, Fernando Wyss, E.J. Posada, Rodolfo Milesi, C. Lopez-Albizu, R.R. Milesi, L.E. Echeverría, J.A. Perez-Molina, I. Molina, Brandi Meeks, Sergio Sosa-Estani, Lindsey Whalen, Werner Apt, Hugo Colombo, M. Fernandez, Carlos Morillo, N. Prado, Hetty Waskin, M.C. Bangher, I. Zulantay, J.S. Beloscar, Marcelo Mallagray, Iris Holadyk-Gris, Sosa Estani, Sergio, Apt Baruch, Werner, Morillo, Carlos A., Pérez Molina, José Antonio, Bonilla, Laura R., Bo Wei, Bo, Bangher, María del Carmen, Echeverría, Luis E. +95 morecore +1 more sourcePosaconazole oral dose and plasma levels in pediatric hematology-oncology patients
, 2017 Posaconazole is a triazole with limited pharmacokinetic information in children. This study assessed the correlation between posaconazole-oral-solution daily dosage/kg/body weight and trough plasma ...Francesca Carraro, Perruccio, Katia, Rossin, Sara, Carraro, Francesca, Sara Rossin, Nunzia Decembrino, Mariadelfina Molinaro, Tridello, Gloria, Calore, Elisabetta, Gloria Tridello, Simone Cesaro, Berger, Massimo, Elisabetta Calore, Katia Perruccio, Cesaro, Simone, Massimo Berger, Decembrino, Nunzia, Putti, Maria Caterina, Molinaro, Mariadelfina, Maria Caterina Putti, VICENZI, EDOARDO BRUNO, Edoardo Bruno Vicenzi +21 morecore +1 more sourceIn Vivo
11β-Hydroxysteroid Dehydrogenase Inhibition in Posaconazole-Induced Hypertension and Hypokalemia [PDF]
, 2017 We describe a case of apparent mineralocorticoid excess (AME) secondary to posaconazole therapy and suggest the biochemical mechanism. Clinical and laboratory investigation confirmed 11β-hydroxysteroid dehydrogenase inhibition and withholding therapy led Diana Chang, Ian McHardy, Rebecca R. Wittenberg, McHardy, Ian, George R. Thompson, Thompson, George R, Alison Semrad, Wittenberg, Rebecca R, Chang, Diana, Semrad, Alison +9 morecore +1 more sourcePosaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis
, 2018 Javier Martínez-Casanova,1 Nuria Carballo,1 Sonia Luque,1 Luisa Sorli,2 Santiago Grau1 1Pharmacy Department, Hospital del Mar, Barcelona, Spain; 2Infectious Diseases Department, Hospital del Mar, Barcelona, Spain Abstract: Azole antifungals have ...Santiago Grau, Luque S, Carballo Martínez, Núria, Sorli Redó, M. Luisa, Luisa Sorli, Javier Martínez-Casanova, Grau S, Carballo N, Martínez-Casanova J, Sorli L, Luque Pardos, Sònia, Sonia Luque, Martínez-Casanova, Javier, Grau Cerrato, Santiago, Nuria Carballo +14 morecore +1 more sourceReal-Life Use of Posaconazole in Clinical Practice for Onco-Hematological Children: A National Survey by AIEOP Infectious Diseases Working Group
Journal of FungiBackground: Posaconazole is an antifungal medication used to treat invasive fungal infections (IFI) in pediatric onco-hematological patients. Its approval for pediatric use was recent, and limitations still apply.Lorenzo Chiusaroli, Manuela Spadea, Cecilia Liberati, Maria Grazia Petris, Antonio Grasso, Francesco Baccelli, Maria Vittoria Micheletti, Pietro Gasperini, Maria Rosaria D’Amico, Katia Perruccio, Angelica Barone, Daniela Onofrillo, Paola Muggeo, Maura Faraci, Simona Rinieri, Ilaria Liguoro, Antonella Colombini, Francesca Trevisan, Nagua Giurici, Gianluca Boscarol, Letizia Pomponia Brescia, Alessia Pancaldi, Francesca Compagno, Alessandra Biffi, Daniele Donà, Simone Cesaro +25 moredoaj +1 more sourcePopulation pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients
Critical Care, 2019 Background The population pharmacokinetics of total and unbound posaconazole following intravenous administration has not yet been described for the critically ill patient population. The aim of this work was, therefore, to describe the total and unbound Fekade B. Sime, Catherine J. Byrne, Suzanne Parker, Janine Stuart, Jenie Butler, Therese Starr, Saurabh Pandey, Steven C. Wallis, Jeffrey Lipman, Jason A. Roberts +9 moredoaj +1 more sourceFailure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole
, 2011 Contains fulltext :
96921.pdf (Publisher’s version ) (Open Access)We report the case of a kidney transplant recipient with invasive aspergillosis due to Aspergillus fumigatus resistant to voriconazole and intermediately susceptible to ...Paul E. Verweij, Melchers, W.J.G., Sevaux, R.G. de, Ruud G. L. de Sévaux, Saskia Kuipers, Kuipers, S., Verweij, P.E., Willem J. G. Melchers, Johan W. Mouton, Mouton, J.W., Roger J. M. Brüggemann, Heesakkers, J.P.F.A., Bruggemann, R.J.M., John P. F. A. Heesakkers +13 morecore +1 more source